搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Human HLA class I histocompatibility antigen, B-15 alpha chain (HLA-B), partial CSB-YP326975HU
CSB-EP326975HU
CSB-BP326975HU
CSB-MP326975HU
CSB-EP326975HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human HLA class I histocompatibility antigen, B-47 alpha chain (HLA-B), partial CSB-YP326976HU
CSB-EP326976HU
CSB-BP326976HU
CSB-MP326976HU
CSB-EP326976HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human HLA class I histocompatibility antigen, B-53 alpha chain (HLA-B), partial CSB-YP326977HU
CSB-EP326977HU
CSB-BP326977HU
CSB-MP326977HU
CSB-EP326977HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human HLA class I histocompatibility antigen, Cw-8 alpha chain (HLA-C), partial CSB-YP326978HU
CSB-EP326978HU
CSB-BP326978HU
CSB-MP326978HU
CSB-EP326978HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saguinus oedipus Saoe class I histocompatibility antigen, A alpha chain, partial CSB-YP326979SWB
CSB-EP326979SWB
CSB-BP326979SWB
CSB-MP326979SWB
CSB-EP326979SWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Triticum aestivum Glucose-1-phosphate adenylyltransferase small subunit, chloroplastic/amyloplastic (AGP-S), partial CSB-YP326980TQN
CSB-EP326980TQN
CSB-BP326980TQN
CSB-MP326980TQN
CSB-EP326980TQN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Tyrosine-protein kinase receptor UFO (AXL), partial CSB-YP326981HU
CSB-EP326981HU
CSB-BP326981HU
CSB-EP326981HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacillus stearothermophilus 1,4-alpha-glucan branching enzyme GlgB (glgB), partial CSB-YP326982GFM
CSB-EP326982GFM
CSB-BP326982GFM
CSB-MP326982GFM
CSB-EP326982GFM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida albicans Enolase 1 (ENO1) CSB-YP326983CZD
CSB-EP326983CZD
CSB-BP326983CZD
CSB-MP326983CZD
CSB-EP326983CZD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans Chitin synthase C (chsC), partial CSB-YP326984EKF
CSB-EP326984EKF
CSB-BP326984EKF
CSB-MP326984EKF
CSB-EP326984EKF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaeococcomyces exophialae Chitin synthase 1 (CHS1) CSB-YP326985PGP
CSB-EP326985PGP
CSB-BP326985PGP
CSB-MP326985PGP
CSB-EP326985PGP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Chitin synthase 1 (chs1), partial CSB-YP326986SXV
CSB-EP326986SXV
CSB-BP326986SXV
CSB-MP326986SXV
CSB-EP326986SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chitin synthase 2 (CHS2) CSB-YP326987XAU
CSB-EP326987XAU
CSB-BP326987XAU
CSB-MP326987XAU
CSB-EP326987XAU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Protein transport protein SEC1 (SEC1), partial CSB-YP326988SVG
CSB-EP326988SVG
CSB-BP326988SVG
CSB-MP326988SVG
CSB-EP326988SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable glutathione reductase 2 (trxr-2), partial CSB-YP326989CXY
CSB-EP326989CXY
CSB-BP326989CXY
CSB-MP326989CXY
CSB-EP326989CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Suid herpesvirus 1 Serine/threonine-protein kinase UL13 (UL13) CSB-YP326990SRJ
CSB-EP326990SRJ
CSB-BP326990SRJ
CSB-MP326990SRJ
CSB-EP326990SRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Murid herpesvirus 1 Envelope glycoprotein H (gH), partial CSB-YP326991MJT1
CSB-EP326991MJT1
CSB-BP326991MJT1
CSB-MP326991MJT1
CSB-EP326991MJT1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neisseria meningitidis serogroup B Major outer membrane protein P.IB (porB) CSB-YP326992NBK
CSB-BP326992NBK
CSB-MP326992NBK
CSB-EP326992NBK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Flaveria trinervia C4 phosphoenolpyruvate carboxylase (PPCA), partial CSB-YP326993FEU
CSB-EP326993FEU
CSB-BP326993FEU
CSB-MP326993FEU
CSB-EP326993FEU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa 10 kDa chaperonin (groS) CSB-YP326994EZX
CSB-EP326994EZX
CSB-BP326994EZX
CSB-MP326994EZX
CSB-EP326994EZX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>